CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy

Mol Immunol. 2013 Dec;56(4):513-20. doi: 10.1016/j.molimm.2013.04.015. Epub 2013 Aug 1.

Abstract

Leprosy is a chronic human disease that results from infection of Mycobacterium leprae. T reg cells have been shown to have important implications in various diseases. However, in leprosy, it is still unclear whether T regs can mediate immune suppression during progression of the disease. In the present study, we have proposed the putative mechanism leading to high proportion of T reg cells and investigated its significance in human leprosy. High levels of TGF-β followed by adaptation of FoxP3(+) naive and memory (CD4(+)CD45RA(+)/RO(+)) T cells were observed as the principal underlying factors leading to higher generation of T reg cells during disease progression. Furthermore, TGF-β was found to be associated with increased phosphorylation-mediated-nuclear-import of SMAD3 and NFAT towards BL/LL pole to facilitate FoxP3 expression in these cells, the same as justified after using nuclear inhibitors of SMAD3 (SIS3) and NFAT (cyclosporin A) in CD4(+)CD25(+) cells in the presence of TGF-β and IL-2. Interestingly, low ubiquitination of FoxP3 in T reg cells of BL/LL patients was revealed to be a major driving force in conferring stability to FoxP3 which in turn is linked to suppressive potential of T regs. The present study has also pinpointed the presence of CD4(+)CD25(+)IL-10(+) sub class of T regs (Tr1) in leprosy.

Keywords: Acetylated FoxP3; Leprosy; M. leprae; T regs; Tr1; Ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Active Transport, Cell Nucleus / drug effects
  • Adolescent
  • Adult
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Cyclosporine / pharmacology
  • Female
  • Forkhead Transcription Factors / immunology*
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Interleukin-2 / immunology
  • Interleukin-2 / metabolism
  • Interleukin-2 / pharmacology
  • Interleukin-2 Receptor alpha Subunit / immunology*
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Isoquinolines / pharmacology
  • Leprosy / immunology*
  • Leprosy / metabolism
  • Leprosy / pathology
  • Leukocyte Common Antigens / immunology
  • Leukocyte Common Antigens / metabolism
  • Male
  • Middle Aged
  • NFATC Transcription Factors / antagonists & inhibitors
  • NFATC Transcription Factors / immunology
  • NFATC Transcription Factors / metabolism
  • Phosphorylation / drug effects
  • Pyridines / pharmacology
  • Pyrroles / pharmacology
  • Smad3 Protein / antagonists & inhibitors
  • Smad3 Protein / immunology
  • Smad3 Protein / metabolism
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism
  • Transforming Growth Factor beta / immunology
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta / pharmacology
  • Ubiquitination
  • Young Adult

Substances

  • 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • IL2RA protein, human
  • Immunosuppressive Agents
  • Interleukin-2
  • Interleukin-2 Receptor alpha Subunit
  • Isoquinolines
  • NFATC Transcription Factors
  • Pyridines
  • Pyrroles
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Cyclosporine
  • Leukocyte Common Antigens